Skip to main content
. 2008 Oct 30;23(5):825–832. doi: 10.3346/jkms.2008.23.5.825

Fig. 7.

Fig. 7

Tumors were taken at 8 weeks from treatment from mice treated with pΔNp63-shRNA (A1), pΔNp63-cRNA (A2) or PBS (A3) and their sizes were measured and shown in B.

*Statistically significant (p<0.05, mean±SD, n=6) relative to pΔNp63-cRNA group.